{"mainPropery":{"diseaseId":12182,"diseaseName":"PIK3CA-related overgrowth spectrum","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12182/pik3ca-related-overgrowth-spectrum","synonyms":["PIK3CA-associated segmental overgrowth"],"synonyms-with-source":[{"name":"PIK3CA-associated segmental overgrowth","source":""}],"identifiers":[]},"diseaseCategories":[],"organizations":[{"resourceID":402,"resourceName":"Klippel-Trenaunay Support Group","abbreviation":"K-T Support Group","address1":"1471 Greystone Lane","address2":"","address3":"","address4":"","address5":"","city":"Milford","state":"OH","zip":"45150","country":"United States","phone":"+1-513-722-7724","tty":"","tollFree":"","fax":"","email":"support@k-t.org","url":"https://k-t.org/","freeText":"Contact form: https://k-t.org/about-us/contact"},{"resourceID":750,"resourceName":"M-CM Network","abbreviation":"","address1":"PO Box 97","address2":"","address3":"","address4":"","address5":"","city":"Chatham","state":"NY","zip":"12037","country":"United States","phone":"518-392-2150","tty":"","tollFree":"","fax":"","email":"hello@m-cm.net","url":"http://www.m-cm.net/","freeText":""},{"resourceID":844,"resourceName":"CLOVES Syndrome Community","abbreviation":"","address1":"PO Box 406","address2":"","address3":"","address4":"","address5":"","city":"West Kennebunk","state":"ME","zip":"04094","country":"United States","phone":"","tty":"","tollFree":"1-833-425-6837 (1-833-4CLOVES)","fax":"","email":"info@clovessyndrome.org","url":"https://www.clovessyndrome.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=pik3ca-related+overgrowth+spectrum' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss PIK3CA-related overgrowth spectrum. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK153722/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2506,"resourceId":3815,"resourceName":"The University of Cambridge","descriptionText":"<a href='http://www.overgrowthstudy.medschl.cam.ac.uk/for-patientsparents/' target='_blank'>The University of Cambridge</a> has a resource about segmental overgrowth and opportunities to enroll in a database for future research opportunities.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with PIK3CA-related overgrowth spectrum. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;PIK3CA-related overgrowth spectrum:<br />\r\n<a href='http://www.clovessyndrome.org/cloves-contact-registry' target='_blank'>CLOVES Contact Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":12546,"questionText":"What is <em>PIK3CA</em>-related overgrowth spectrum (PROS)?","answerText":"<strong><em>PIK3CA</em>-related overgrowth spectrum (PROS)&nbsp;</strong>is a group of rare disorders that cause <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=367429\">overgrowth</a>&nbsp;of parts of the body, due to mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/PIK3CA\" target=\"_blank\">PIK3CA</a></em> gene. Specific disorders in this spectrum include:[12611][14782][14783][14784]<br />\r\n<ul style=\"list-style-type: disc;\">\r\n    <li><a href=\"https://www.texaschildrens.org/health/fibroadipose-hyperplasia-fh\">Fibroadipose hyperplasia</a>&nbsp;(also called fibroadipose overgrowth)</li>\r\n    <li><a href=\"https://rarediseases.info.nih.gov/diseases/10939/cloves-syndrome\">CLOVES syndrome</a></li>\r\n    <li><a href=\"https://rarediseases.info.nih.gov/diseases/6950/macrocephaly-capillary-malformation\" target=\"_blank\">Megalencephaly-capillary malformation syndrome</a>&nbsp;(MCAP syndrome)</li>\r\n    <li><a href=\"https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=276280\" target=\"_blank\">Hemihyperplasia‐multiple lipomatosis syndrome</a> (HHML syndrome)</li>\r\n    <li><a href=\"https://rarediseases.info.nih.gov/diseases/2637/hemimegalencephaly\" target=\"_blank\">Hemimegalencephaly</a></li>\r\n    <li><a href=\"https://rarediseases.info.nih.gov/diseases/13647/facial-infiltrating-lipomatosis\" target=\"_blank\">Facial infiltrating lipomatosis</a> (a congenital disorder that causes overgrowth of one side of the face)</li>\r\n</ul>\r\nSigns and symptoms of PROS depend on the specific disorder present. Depending on the disorder, they can include having a larger-than-normal brain (<a href=\"https://www.ninds.nih.gov/Disorders/All-Disorders/Megalencephaly-Information-Page\">megalencephaly</a>), low muscle tone (<a href=\"https://medlineplus.gov/ency/article/003298.htm\">hypotonia</a>), <a href=\"https://medlineplus.gov/seizures.html\">seizures</a>, <a href=\"https://medlineplus.gov/ency/article/001523.htm\">intellectual disability</a>, changes in the blood vessels (<a href=\"https://medlineplus.gov/vasculardiseases.html\">vascular system),</a> and overgrowth of one area of the body (focal overgrowth) or of multiple areas of the body (segmental overgrowth), with normal growth elsewhere.[12611]<br />\r\n<br />\r\nPROS is usually caused by somatic mutations in the <a href=\"https://ghr.nlm.nih.gov/gene/PIK3CA\"><em>PIK3CA</em></a> <a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>. These changes typically are only present in some cells or some areas of the body (called mosaicism), and are not known to be inherited. Rarely, PROS is caused by a <em>de novo</em> germline mutation, which is present in all cells of the body. The diagnosis of a PROS disorder can be confirmed with <a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a> of the <em>PIK3CA </em>gene. Treatment for a PROS disorder may involve surgical interventions, <a href=\"https://www.understood.org/en/school-learning/special-services/ieps/understanding-individualized-education-programs\">special education</a>, and <a href=\"http://www.asha.org/Students/Speech-Language-Pathology/\">speech</a> and <a href=\"http://www.wcpt.org/what-is-physical-therapy\">physical therapies</a>.[12611]","dateModified":"2018-07-10T00:00:00"},"basicQuestions":[{"questionId":12547,"questionText":"What are the signs and symptoms of <em>PIK3CA-</em>related overgrowth spectrum (PROS)?","answerText":"The signs and symptoms of <em>PIK3CA</em>-related overgrowth spectrum (PROS) vary depending on the particular disorder each person has. for example:<br />\r\n<strong>\r\n<br />\r\nCLOVES syndrome</strong> is associated with fatty (<a href=\"https://medlineplus.gov/ency/imagepages/1209.htm\">lipomatous</a>) growths that typically affect the trunk; blood vessel differences (<a href=\"https://medlineplus.gov/vasculardiseases.html\">vascular malformations</a>); patches or growths on the skin (<a href=\"https://ghr.nlm.nih.gov/condition/epidermal-nevus\">epidermal nevi</a>); and differences in the bones (skeletal system). Skeletal abnormalities can include a curve in the spine (<a href=\"https://medlineplus.gov/scoliosis.html\">scoliosis</a>) and having very large fingers or toes (<a href=\"http://www.childrenshospital.org/conditions-and-treatments/conditions/macrodactyly\">macrodactyly</a>). <strong>Fibroadipose hyperplasia</strong> typically has signs and symptoms that are very similar to those of CLOVES syndrome.[12611]<br />\r\n<br />\r\n<strong>Megalencephaly-capillary malformation syndrome (MCAP syndrome)</strong> is associated with having a very large brain (<a href=\"https://www.ninds.nih.gov/Disorders/All-Disorders/Megalencephaly-Information-Page\">megalencephaly</a>) or having one half of the brain larger than expected (<a href=\"https://rarediseases.org/rare-diseases/hemimegalencephaly/\"><strong>hemimegalencephaly</strong></a>).&nbsp; It also causes differences in the smallest blood vessels, called the <a href=\"https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0022018/\">capillaries</a>. Megalencephaly can cause symptoms including low muscle tone (<a href=\"https://medlineplus.gov/ency/article/003298.htm\">hypotonia</a>), <a href=\"https://medlineplus.gov/seizures.html\">seizures</a>, and <a href=\"https://medlineplus.gov/ency/article/001523.htm\">intellectual disability</a>. Other features of MCAP syndrome may include having fingers or toes that are fused together (<a href=\"https://medlineplus.gov/ency/imagepages/1763.htm\">syndactyly</a>), having extra fingers or toes (<a href=\"https://medlineplus.gov/ency/article/003176.htm\">polydactyly</a>), and being very flexible (<a href=\"https://medlineplus.gov/ency/article/003295.htm\">joint hypermobility</a>). Some people with MCAP syndrome may have heart anomalies.[12611] <br />\r\n<br />\r\n<strong>Hemihyperplasia‐multiple lipomatosis syndrome (HHML syndrome)</strong> is associated with&nbsp;non-progressive, asymmetrical, moderate overgrowth usually affecting the limbs. It is also associated with slow-growing, painless, subcutaneous lipomatous masses (made up of fat cells) distributed throughout the body. Vascular malformations may also be present.[14785]<br />\r\n<br />\r\n<strong>Facial infiltrating lipomatosis (FIL)</strong> causes overgrowth and enlargement of one side of the face. It can also cause&nbsp;mucosal neuromas (masses that grow from a nerve), hemimacroglossia (enlargement of half of the tongue), bone enlargement, and premature dental eruption.[14784]<br />\r\n<br />\r\nBecause PROS causes cells of the body to grow and divide more quickly, there is an increased risk of cancer in people with some forms of PROS.[14299] <em>PIK3CA</em>&nbsp;mutations are frequently found in the tumors of people without PROS in many cancers including colon, breast, brain, liver, stomach, and lung.[12611]","dateModified":"2018-07-10T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":12611,"authors":"Mirzaa G, Conway R,Graham JM, and Dobyns WB.","articleTitle":"PIK3CA-Related Segmental Overgrowth","bookWebsiteJournalTitle":"GeneReviews","date":"August 15 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK153722/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14299,"authors":"Gripp KW, Baker L, Kandula V, Conard K, Scavina M, Napoli JA, Griffin GC, Thacker M, Knox RG, Clark GR, Parker VE, Semple R, Mirzaa G, and Keppler-Noreuil KM","articleTitle":"Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation","bookWebsiteJournalTitle":"American Journal of Medical Genetics","date":"October 2016","volume":"170(10)","pages":"2559-2569","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514817/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14784,"authors":"Couto JA, Konczyk DJ, Vivero MP, et al","articleTitle":"Somatic PIK3CA Mutations are Present in Multiple Tissues of Facial Infiltrating Lipomatosis","bookWebsiteJournalTitle":"Pediatr Res","date":"November, 2017","volume":"82(5)","pages":"850-854","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645230/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14785,"authors":"","articleTitle":"Hemihyperplasia-multiple lipomatosis syndrome","bookWebsiteJournalTitle":"Orphanet","date":"","volume":"","pages":"","url":"https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=276280","dateAccessed":"2018-07-10T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12548,"questionText":"What causes&nbsp;<em>PIK3CA-</em>related overgrowth spectrum (PROS)?","answerText":"<em>PIK3CA</em>-related overgrowth spectrum (PROS) is caused by changes in the <a href=\"https://ghr.nlm.nih.gov/gene/PIK3CA\"><em>PIK3CA</em></a> <a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>. When a genetic change causes a syndrome, it is also known as a <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutation</a> or pathogenic variant. The <em>PIK3CA</em> gene provides instructions to the body to make a protein that helps control the signaling of other proteins. This protein therefore helps many processes occur at the correct times including cell growth and division, cell movement, and cell survival. When there is a change in the <em>PIK3CA</em> gene, the body does not receive instructions to make the signaling protein correctly. This causes mistakes in cell growth and division and how long a cell survives. If cells are dividing too quickly or if they survive longer than they should, overgrowth of that part of the body can occur. This causes the signs and symptoms associated with PROS.[14300]<br />","dateModified":"2018-01-29T19:24:00","resourceClassificationName":"Cause","references":[{"referenceId":14300,"authors":"","articleTitle":"PIK3CA gene","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August 2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/gene/PIK3CA","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12549,"questionText":"Is&nbsp;<em>PIK3CA</em>-related overgrowth spectrum (PROS) inherited?","answerText":"<em>PIK3CA</em><span>-related overgrowth spectrum (PROS) is not known to be inherited at this time. There are no confirmed reports of transmission of PROS from a parent to a child, and there are no reports of siblings having PROS.[12611]<br />\r\n<br />\r\nMost people with PROS have a&nbsp;<em>somatic</em>&nbsp;mutation</span><span>&nbsp;in the </span><a href=\"https://ghr.nlm.nih.gov/gene/PIK3CA\"><em>PIK3CA</em></a><span> </span><span><a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>, which is a genetic change that is not inherited, occurring randomly <em>after</em>&nbsp;fertilization (the joining of the egg and the sperm).[12611] Somatic mutations occur in cells other than egg and sperm cells (which are called gametes), and ultimately are only present in the cells that originate from the cell in which the mutation occurred. This is called </span><a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\"><span>somatic mosaicism</span></a><span>. A person with somatic mosaicism cannot pass the mutation on to his/her children when the mutation is not present in the gametes. The siblings of a person with PROS due to somatic mosaicism also are not thought to have an increased risk to have PROS.[12611]</span><br />\r\n<br />\r\nRarely, a person with PROS has a <em>germline</em> mutation (a genetic change in a person's egg or sperm cell), which means the mutation is present in all of that person's cells. However, in the reported cases of germline mutations causing PROS, the mutations have occurred for the first time in the person with PROS and have not been inherited from either parent.[12611] These are called <em>de novo</em> mutations. Each child of a person with a <em>de novo</em> germline mutation has a 50% chance of inheriting the mutation. However as noted above, PROS in both a parent and child has not been reported. Siblings of a person with a <em>de novo</em>&nbsp;germline mutation theoretically have a 1% risk to have PROS, due to the possibility of germline mosaicism in a parent.[12611]","dateModified":"2018-01-29T19:26:00","resourceClassificationName":"Inheritance","references":[{"referenceId":12611,"authors":"Mirzaa G, Conway R,Graham JM, and Dobyns WB.","articleTitle":"PIK3CA-Related Segmental Overgrowth","bookWebsiteJournalTitle":"GeneReviews","date":"August 15 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK153722/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12550,"questionText":"How is&nbsp;<em>PIK3CA</em>-related overgrowth spectrum (PROS) diagnosed?","answerText":"A diagnosis of <em>PIK3CA</em>-related overgrowth spectrum (PROS) is often suspected based on characteristic signs and symptoms of the syndromes. For example, <a href=\"https://rarediseases.info.nih.gov/diseases/6950/macrocephaly-capillary-malformation\">megalencephaly-capillary malformation syndrome (MCAP syndrome)</a> can be diagnosed based on findings of megalencephaly and characteristic malformations of the smallest blood vessels (<a href=\"https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0022018/\">capillaries</a>). CLOVES syndrome can be similarly diagnosed by observing signs and symptoms such as <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=367429\">overgrowth</a>, capillary malformations, skin findings, and skeletal abnormalities.[12611][14301]<br />\r\n<br />\r\nA diagnosis of PROS can be confirmed with <a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a> of the <a href=\"https://ghr.nlm.nih.gov/gene/PIK3CA\"><em>PIK3CA</em></a> <a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>. However, some people with these syndromes may have normal (negative) genetic testing. This is because the genetic changes (<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutations</a> or pathogenic variants) are only in some cells of the body. Therefore, multiple samples of different tissues may need to be tested for the <em>PIK3CA </em>genetic changes. In some cases, even if multiple tissues are tested, the diagnosis is not able to be confirmed with genetic testing.[12611] &nbsp;<br />","dateModified":"2018-01-29T19:28:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":12611,"authors":"Mirzaa G, Conway R,Graham JM, and Dobyns WB.","articleTitle":"PIK3CA-Related Segmental Overgrowth","bookWebsiteJournalTitle":"GeneReviews","date":"August 15 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK153722/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14301,"authors":"Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC, Alomari A, Ezaki M, Dobyns W, Dobyns W, and Biesecker LG","articleTitle":"PIK3CA-Related Overgrowth Spectrum (PROS): Diagnostic and Testing Eligibility Criteria, Differential Diagnosis, and Evaluation","bookWebsiteJournalTitle":"American Journal of Medical Genetics","date":"February 2015","volume":"167(2)","pages":"287-295","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480633/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12551,"questionText":"How might&nbsp;<em>PIK3CA-</em>related overgrowth spectrum (PROS) be treated?","answerText":"Unfortunately, there is no cure for <em>PIK3CA</em>-related overgrowth spectrum (PROS). However, there are treatment options that can help manage symptoms of the syndromes. People with <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=367429\">overgrowth</a> may be treated with surgery to remove growths that are impacting movement. Surgery may also be necessary if there is too much pressure on the brain or to treat skeletal symptoms such as <a href=\"https://medlineplus.gov/scoliosis.html\">scoliosis</a>. Medications may be used to treat seizures (<a href=\"https://medlineplus.gov/seizures.html\">epilepsy</a>).[12611] Researchers are investigating other potential medications that may be used to treat PROS.[14302][14303]&nbsp;<br />\r\n<br />\r\nPeople with PROS may be followed by a multi-disciplinary team that may include a <a href=\"https://www.healthline.com/health/neurologist\">neurologist</a>, <a href=\"https://www.cardiosmart.org/Heart-Basics/What-is-a-Cardiologist\">cardiologist</a>, <a href=\"http://www.kidneycarega.com/what-is-nephrology\">nephrologist</a> (doctor that helps manage kidney problems), and an <a href=\"https://orthoinfo.aaos.org/en/treatment/orthopaedics/\">orthopedist</a>. Other treatment options may include <a href=\"http://www.asha.org/Students/Speech-Language-Pathology/\">speech therapy</a>, <a href=\"http://www.wcpt.org/what-is-physical-therapy\">physical therapy</a>, and <a href=\"https://www.understood.org/en/school-learning/special-services/ieps/understanding-individualized-education-programs\">special education</a> in school.[12611]&nbsp;&nbsp;<br />","dateModified":"2018-01-29T19:32:00","resourceClassificationName":"Treatment","references":[{"referenceId":12611,"authors":"Mirzaa G, Conway R,Graham JM, and Dobyns WB.","articleTitle":"PIK3CA-Related Segmental Overgrowth","bookWebsiteJournalTitle":"GeneReviews","date":"August 15 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK153722/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14302,"authors":"Suzuki Y, Enokido Y, Yamada K, Inaba M, Kuwata K, Hanada N, Morishita T, Mizuno S, and Wakamatsu N","articleTitle":"The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS)","bookWebsiteJournalTitle":"Oncotarget","date":"July 11, 2017","volume":"8(28)","pages":"45470-45483","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542201/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14303,"authors":"Keppler-Noreuil KM, Parker VER, Darling TN, and Martinez-Agosto JA","articleTitle":"Somatic Overgrowth Disorders of the PI3K/mTOR Pathway & Therapeutic Strategies","bookWebsiteJournalTitle":"American Journal of Medical Genetics Part C: Seminars in Medical Genetics","date":"December 2016","volume":"172(4)","pages":"402-421","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592089/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12552,"questionText":"What is the long-term outlook for people with&nbsp;<em>PIK3CA</em>-related overgrowth spectrum?","answerText":"People with <em>PIK3CA</em>-related overgrowth syndrome (PROS) may struggle with severe <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=367429\">overgrowth</a>. This may mean that they require surgery to help remove some of the extra tissue, especially if it is causing trouble in day-to-day life. Unfortunately, the syndromes can also be associated with other health problems that can make daily life difficult.[12611][14303] If overgrowth affects the brain and creates too much pressure, there can be side-effects such as <a href=\"https://medlineplus.gov/ency/article/001523.htm\">intellectual disability</a> and <a href=\"https://medlineplus.gov/developmentaldisabilities.html\">developmental delay</a>.[12611] &nbsp;<br />","dateModified":"2018-01-29T19:37:00","resourceClassificationName":"Prognosis","references":[{"referenceId":12611,"authors":"Mirzaa G, Conway R,Graham JM, and Dobyns WB.","articleTitle":"PIK3CA-Related Segmental Overgrowth","bookWebsiteJournalTitle":"GeneReviews","date":"August 15 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK153722/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14303,"authors":"Keppler-Noreuil KM, Parker VER, Darling TN, and Martinez-Agosto JA","articleTitle":"Somatic Overgrowth Disorders of the PI3K/mTOR Pathway & Therapeutic Strategies","bookWebsiteJournalTitle":"American Journal of Medical Genetics Part C: Seminars in Medical Genetics","date":"December 2016","volume":"172(4)","pages":"402-421","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592089/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":10939,"relatedDiseaseName":"CLOVES syndrome","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":13647,"relatedDiseaseName":"Facial infiltrating lipomatosis","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":2637,"relatedDiseaseName":"Hemimegalencephaly","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"PIK3CA-related_overgrowth_spectrum"}